Skip to main content
. 2015 Dec 31;94(52):e2369. doi: 10.1097/MD.0000000000002369

FIGURE 5.

FIGURE 5

Expression of CD158a/CD16+ (A) and CD158b/CD16+ (B) on the surface of NKs in studied groups and the controls. At start of treatment n = 21 patients, at the end of ICHT n = 22 patients, at the end of treatment n = 23 patients, controls n = 43 patients. ICHT = intensive chemotherapy, NK = natural killer.